Clinical Trials Browser

Phase 1/2 × Adenomatous Polyposis Coli × 90 days × Clear all

NCT07463599 2026-03-11

Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma

Phase 1/2 Recruiting

Gastrointestinal

Adenomatous Polyposis Coli, Colorectal Neoplasms